1. Home
  2. Mutual Funds
  3. Monthly Rebalance NASDAQ-100® 2x Strategy

Monthly Rebalance NASDAQ-100® 2x Strategy

Price $580.56
Change ($11.03) / -1.86%
As of 7/19/24

Investment Strategy

Seeks to provide investment results that match, before fees and expenses, 200% of the monthly performance of the NASDAQ-100 Index®.

Fund Highlights and Applications

  • Employs a strategy that seeks to magnify the index’s exposure 200% on a monthly basis
  • Provides enhanced exposure to an underlying benchmark per dollar invested
  • Intended for investors who expect the NASDAQ-100® Index to go up and want accelerated investment gains when it does so. However, there is an increased risk of accelerated losses if the market declines.


Most Recent Income $16.488051
Dividend $0.596164
Most Recent Capital Gain $15.891887

Fees and Expenses

Gross Expense Ratio 1.79%
Net Expense Ratio 1.34%  

Estimated Exposure Level

Retrieving exposure level...
Download Historical Exposure Levels

Symbols & CUSIPs

Class Symbol CUSIP Inception
A RMQAX 78356C562 11/28/14
C RMQCX 78356C554 11/28/14
H RMQHX 78356C547 11/28/14

Investment Team

Team Managed 


Fund Type Rydex
Distribution Frequency Annual (if applicable)
Benchmark NASDAQ-100 Index
Telephone 800.820.0888
Trading Hours Phone: 9:30 AM - 3:45 PM ET
Web: 9:30 AM - 3:55 PM ET
Note: Each financial intermediary may have its own rules about shares transactions, and may have earlier cut - off times for processing your transaction.
Investment Adviser Security Investors, LLC
Distributor Guggenheim Funds Distributors, LLC
* Estimated Current Exposure Level data updated as often as once per minute. Refresh this web page to obtain updated data.

Performance displayed represents past performance which is no guarantee of future results. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Current performance may be lower or higher than the performance data quoted. Returns for performance under one year are cumulative, not annualized. Performance shown reflects maximum sales charges or contingent deferred sales charges (CDSC) as applicable. Class A-shares have a maximum sales charge of 4.75%. Class C-shares have a maximum CDSC of 1% for shares redeemed within 12 months of purchase.

Data is subject to change on a daily basis. Partial year returns are cumulative, not annualized. Returns reflect the reinvestment of dividends.

Monthly leveraged funds are not suitable for all investors. • These funds should be utilized only by investors who (a) understand the risks associated with the use of leverage, (b) understand the consequences of seeking monthly leveraged investment results, and (c) intend to actively monitor and manage their investments.• The more a fund invests in leveraged instruments, the more the leverage will magnify any gains or losses on those investments. • The funds’ use of derivatives, such as futures, options and swap agreements, may expose the funds’ shareholders to additional risks that they would not be subject to if they invested directly in the securities underlying those derivatives. • Monthly leveraged funds seek to provide investment results that match the performance of a specific benchmark, before fees and expenses, on a monthly basis. Because monthly leveraged funds seek to track the performance of their benchmark on a monthly basis, mathematical compounding, especially with respect to those funds that use leverage as part of their investment strategy, may prevent a fund from correlating with the quarterly, annual or other period performance of its benchmark. Due to the compounding of monthly returns, leveraged funds’ returns over periods other than one calendar month will likely differ in amount and possibly direction from the benchmark return for the same period. For those funds that consistently apply leverage, the value of the funds’ shares will tend to increase or decrease more than the value of any increase or decrease in its benchmark index. Monthly leveraged funds rebalance their portfolios on a monthly basis on the last day of each calendar month, increasing exposure in response to that month’s gains or reducing exposure in response to that month’s losses. • Throughout the month, the amount of leverage that a monthly leveraged fund provides is allowed to float. Purchasing monthly leveraged funds on any day other than the last day of each calendar month will likely mean that the monthly leveraged fund’s actual leverage is different from its monthly leverage target. Investors should monitor their monthly leveraged funds’ holdings consistent with their strategies, as frequently as daily. • For more on these and other risks, please read the monthly leveraged funds’ prospectus.

NASDAQ®, NASDAQ-100®, and NASDAQ-100 Index®, are registered trademarks of The NASDAQ OMX Group, Inc. (which with its affiliates is referred to as the “Corporations”) and are licensed for use by Guggenheim Investments. The Fund have not been passed on by the Corporations as to their legality or suitability. Guggenheim funds are not issued, endorsed, sold or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO GUGGENHEIM INVESTMENTS FUNDS.

The Advisor has contractually agreed to waive the management fee it receives from the Fund in an amount equal to the management fee paid to the Advisor by the Subsidiary through August 1, 2024. Read the prospectus for more information regarding fees and expenses.

Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.

Investing involves risk, including the possible loss of principal.

Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC.

© 2024 Guggenheim Investments. All Rights Reserved.

Research our firm with FINRA Broker Check.

• Not FDIC Insured • No Bank Guarantee • May Lose Value

This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.